Last reviewed · How we verify
pirfenidone and nintedanib
pirfenidone and nintedanib is a Small molecule drug developed by Hospices Civils de Lyon. It is currently FDA-approved.
At a glance
| Generic name | pirfenidone and nintedanib |
|---|---|
| Sponsor | Hospices Civils de Lyon |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD
- Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis (PHASE3)
- A Phase 1, Open-Label Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants (PHASE1)
- Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis (PHASE3)
- Management of Progressive Disease in Idiopathic Pulmonary Fibrosis (PHASE4)
- Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients (PHASE1)
- To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF (PHASE2)
- A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- pirfenidone and nintedanib CI brief — competitive landscape report
- pirfenidone and nintedanib updates RSS · CI watch RSS
- Hospices Civils de Lyon portfolio CI
Frequently asked questions about pirfenidone and nintedanib
What is pirfenidone and nintedanib?
pirfenidone and nintedanib is a Small molecule drug developed by Hospices Civils de Lyon.
Who makes pirfenidone and nintedanib?
pirfenidone and nintedanib is developed and marketed by Hospices Civils de Lyon (see full Hospices Civils de Lyon pipeline at /company/hospices-civils-de-lyon).
What development phase is pirfenidone and nintedanib in?
pirfenidone and nintedanib is FDA-approved (marketed).
Related
- Manufacturer: Hospices Civils de Lyon — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing